Literature DB >> 11035703

Pheochromocytoma crisis, cardiomyopathy, and hemodynamic collapse.

J R Kizer1, L S Koniaris, J D Edelman, M G St John Sutton.   

Abstract

Pheochromocytoma is a notorious clinical entity. Although suspicion is aroused by severe hypertension in young patients, this sign is often absent. We present a case in which early absence of hypertension and nonspecific signs and symptoms led to failure of prompt diagnosis. The delay proved fatal when the patient developed fulminant pheochromocytoma crisis. This case illustrates a variety of clinical features seen from the vantage of the evolution of the disease as it went unrecognized. The patient's course underscores the importance of familiarity with the gamut of manifestations for timely diagnosis, and the priority of the latter given the looming risk of overwhelming complications.

Entities:  

Mesh:

Year:  2000        PMID: 11035703     DOI: 10.1378/chest.118.4.1221

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

Review 1.  Pheochromocytoma as an endocrine emergency.

Authors:  Frederieke M Brouwers; Jacques W M Lenders; Graeme Eisenhofer; Karel Pacak
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  The Challenges of Treating Paraganglioma Patients with (177)Lu-DOTATATE PRRT: Catecholamine Crises, Tumor Lysis Syndrome and the Need for Modification of Treatment Protocols.

Authors:  William Makis; Karey McCann; Alexander J B McEwan
Journal:  Nucl Med Mol Imaging       Date:  2015-04-09

3.  Pheochromocytoma multisystem crisis successfully treated by emergency surgery: report of a case.

Authors:  Naotaka Uchida; Kiyosuke Ishiguro; Takako Suda; Motonobu Nishimura
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

4.  Endomyocardial biopsy in a patient with hemorrhagic pheochromocytoma presenting as inverted Takotsubo cardiomyopathy.

Authors:  Kohei Iio; Shunpei Sakurai; Tamon Kato; Shigeki Nishiyama; Takeki Hata; Eiichiro Mawatari; Chihiro Suzuki; Kazuhiro Takekoshi; Kayoko Higuchi; Toru Aizawa; Uichi Ikeda
Journal:  Heart Vessels       Date:  2012-04-05       Impact factor: 2.037

5.  No evidence for increased mortality in SDHD variant carriers compared with the general population.

Authors:  Leonie T van Hulsteijn; Berdine Heesterman; Jeroen C Jansen; Jean-Pierre Bayley; Frederik J Hes; Eleonora P M Corssmit; Olaf M Dekkers
Journal:  Eur J Hum Genet       Date:  2015-03-11       Impact factor: 4.246

6.  Embolisation of pheochromocytoma to stabilise and wean a patient in cardiogenic shock from emergency extracorporeal life support.

Authors:  Helle Vagner; Thomas Morris Hey; Bo Elle; Marianne Kjær Jensen
Journal:  BMJ Case Rep       Date:  2015-03-03

7.  Clinical characteristics and outcomes of pheochromocytoma crisis: a literature review of 200 cases.

Authors:  Y Ando; Y Ono; A Sano; N Fujita; S Ono; Y Tanaka
Journal:  J Endocrinol Invest       Date:  2022-07-20       Impact factor: 5.467

8.  Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.

Authors:  Bart de Keizer; Maarten O van Aken; Richard A Feelders; Wouter W de Herder; Boen L R Kam; Martijn van Essen; Eric P Krenning; Dik J Kwekkeboom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-16       Impact factor: 9.236

Review 9.  Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease?

Authors:  Jenn Rachelle U Santos; Alessandra Brofferio; Bruna Viana; Karel Pacak
Journal:  Horm Metab Res       Date:  2018-09-18       Impact factor: 2.936

10.  Transient pulmonary edema following adrenal infarction in a patient with primary anti-phospholipid syndrome.

Authors:  K Ozawa; K Tazawa; D Kishida; K Fukushima; M Matsuda; S Ikeda
Journal:  Clin Med Insights Case Rep       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.